These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27430302)

  • 1. miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion.
    Huang J; Wang B; Hui K; Zeng J; Fan J; Wang X; Hsieh JT; He D; Wu K
    Oncol Rep; 2016 Sep; 36(3):1693-701. PubMed ID: 27430302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
    Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor β promotes bladder cancer growth and invasion via alteration of miR-92a/DAB2IP signals.
    Ou Z; Wang Y; Chen J; Tao L; Zuo L; Sahasrabudhe D; Joseph J; Wang L; Yeh S
    Exp Mol Med; 2018 Nov; 50(11):1-11. PubMed ID: 30459405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.
    Hui K; Gao Y; Huang J; Xu S; Wang B; Zeng J; Fan J; Wang X; Yue Y; Wu S; Hsieh JT; He D; Wu K
    Cell Death Dis; 2017 Feb; 8(2):e2600. PubMed ID: 28182001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
    Feng C; Sun P; Hu J; Feng H; Li M; Liu G; Pan Y; Feng Y; Xu Y; Feng K; Feng Y
    Int J Oncol; 2017 Jun; 50(6):2101-2112. PubMed ID: 28440444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-454-3p and miR-374b-5p suppress migration and invasion of bladder cancer cells through targetting ZEB2.
    Wang S; Zhang G; Zheng W; Xue Q; Wei D; Zheng Y; Yuan J
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncARSR sponges miR-129-5p to promote proliferation and metastasis of bladder cancer cells through increasing SOX4 expression.
    Liao C; Long Z; Zhang X; Cheng J; Qi F; Wu S; Huang T
    Int J Biol Sci; 2020; 16(1):1-11. PubMed ID: 31892841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1.
    Yao K; He L; Gan Y; Zeng Q; Dai Y; Tan J
    Diagn Pathol; 2015 Aug; 10():146. PubMed ID: 26290438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer.
    Wu CL; Ho JY; Chou SC; Yu DS
    Oncotarget; 2016 May; 7(18):26593-603. PubMed ID: 27058893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-92b promotes gastric cancer growth by activating the DAB2IP-mediated PI3K/AKT signalling pathway.
    Ni QF; Zhang Y; Yu JW; Hua RH; Wang QH; Zhu JW
    Cell Prolif; 2020 Jan; 53(1):e12630. PubMed ID: 31713929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1.
    Cheng Y; Yang X; Deng X; Zhang X; Li P; Tao J; Lu Q
    Tumour Biol; 2015 Sep; 36(10):8015-23. PubMed ID: 25967457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression.
    Huang J; Lo UG; Wu S; Wang B; Pong RC; Lai CH; Lin H; He D; Hsieh JT; Wu K
    Cell Death Dis; 2019 Jun; 10(6):437. PubMed ID: 31164632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer.
    Sakimura S; Sugimachi K; Kurashige J; Ueda M; Hirata H; Nambara S; Komatsu H; Saito T; Takano Y; Uchi R; Sakimura E; Shinden Y; Iguchi T; Eguchi H; Oba Y; Hoka S; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1436-43. PubMed ID: 25707493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
    Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
    Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-19a promotes invasion and epithelial to mesenchymal transition of bladder cancer cells by targeting RhoB.
    Li Z; Li Y; Wang Y
    J BUON; 2019; 24(2):797-804. PubMed ID: 31128038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promotion of tumour proliferation, migration and invasion by miR-92b in targeting RECK in osteosarcoma.
    Zhou Z; Wang Z; Wei H; Wu S; Wang X; Xiao J
    Clin Sci (Lond); 2016 Jun; 130(11):921-30. PubMed ID: 26993249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
    Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
    Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.
    Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N
    Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer.
    Shen YJ; Kong ZL; Wan FN; Wang HK; Bian XJ; Gan HL; Wang CF; Ye DW
    Cancer Sci; 2014 Jun; 105(6):704-12. PubMed ID: 24684735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.